FGF23 and chronic kidney disease: In chronic kidney disease, elevated levels of fibroblast growth factor 23 inhibited PDE4B expression in cardiomyocytes, further increasing sarcoplasmic reticulum Ca2+ leakage as well as promoting ventricular arrhythmias [29].